Chemicals

2-Benzyl-1H-benzimidazole

We are 2-Benzyl-1H-benzimidazole CAS:621-72-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2-Benzyl-1H-benzimidazole

CAS.NO: 621-72-7

Synonyms:

2-benzyl-1H-benzimidazole

1H-Benzimidazole, 2-(phenylmethyl)-

Molecular Formula: C14H12N2

Molecular Weight: 208.25800

Physical and Chemical Properties:

Density: 1.193 g/cm3

Boiling point: 453.5ºC at 760 mmHg

Melting point: 187ºC

Flash point: 252.1ºC

Refractive index: 1.680

Specification:

Appearance: white or yellow white microfine powder

Purity: >99％

Dechologriseofulvin:Less than 0.60

Dehydrogriseofulvin:Less than 0.15

Substances soluble in light petroleum:NMT 0.20%

Loss on drying:NMT 1.00%

Sulphated ash:NMT 0.20%

Abnormal toxicity:Five mice orals,none of the mice dies within 48h

Assay(anhydrous substance):97.0% to 102.0%

Packing:

25kg cardboard drum or according to customer specified requirements

Storage:Store at 4 ° C.Stored in a well-closed container at low temperature, keep away from moisture, heat and light.

Application:Applicationd to treat hypertension.

2-Benzyl-1H-benzimidazole

Related News: Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology.4-(Trifluoromethoxy)benzenesulfonamide CAS:1513-45-7 Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology.3-aminofenilacetileno CAS:54060-30-9 At the same time, because the profits of a single variety of characteristic APIs do not have long-term growth, companies need more product reserves.4-FLUORO-2-(TRIFLUOROMETHYL)BENZOIC ACID CAS:141179-72-8 At the same time, because the profits of a single variety of characteristic APIs do not have long-term growth, companies need more product reserves.In recent years, with the increasing number of patent medicines whose patents have expired, the variety and quantity of generic drugs have also increased rapidly, which has brought huge market opportunities to the API market and the output of APIs has continued to increase.

Product Name
2,2′-Dibromodiethyl ether	View Details
2,4,6-Trimethylfluorobenzene Cas:392-69-8	View Details
2CZPN Cas:1416881-50-9	View Details